ALX Oncology Inc. (ALXO)
NASDAQ: ALXO
· Real-Time Price · USD
0.64
-0.02 (-2.29%)
At close: Aug 15, 2025, 3:59 PM
0.64
0.59%
After-hours: Aug 15, 2025, 05:02 PM EDT
ALX Oncology Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 868K | n/a | n/a | n/a | 2.48M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 191K | 211K | n/a | 224K | 220K | 214K | 207K | 209K | 513K | 518K | 413K | n/a | 280K | 376K | 259K | 262K | 152K | 5K |
Gross Profit | -191K | -211K | 434K | -224K | -220K | -214K | -207K | -209K | -513K | -518K | -413K | n/a | -280K | -376K | -259K | -262K | -152K | -5K |
Operating Income | -26.65M | -31.82M | -30.61M | -32.57M | -41.52M | -37.76M | -48.02M | -53.27M | -36.78M | -32.2M | -32.22M | -36.68M | -33.79M | -24.75M | -28.47M | -24.58M | -16.3M | -14.21M |
Interest Income | 1.11M | 1.48M | 1.88M | 2.3M | 2.56M | 2.62M | 3M | 2.68M | 2.67M | 2.31M | 1.81M | 1.37M | 876K | 225K | n/a | 22K | 23K | 25K |
Pretax Income | -25.95M | -30.75M | -29.16M | -30.71M | -39.4M | -35.58M | -45.47M | -50.99M | -34.16M | -30.18M | -30.64M | -35.32M | -32.92M | -24.53M | -28.46M | -24.57M | -16.27M | -14.19M |
Net Income | -25.95M | -30.75M | -29.16M | -30.71M | -39.4M | -35.58M | -45.47M | -50.99M | -34.16M | -28.55M | -30.71M | -35.32M | -32.05M | -24.32M | -28.44M | -24.57M | -16.27M | -14.19M |
Selling & General & Admin | 5.45M | 7.93M | 7.08M | 6.1M | 6.65M | 5.83M | 6.03M | 7.51M | 7.29M | 7.44M | 7.02M | 7.3M | 7.04M | 7.67M | 7.58M | 6.36M | 5.09M | 4.36M |
Research & Development | 18.02M | 23.89M | 23.53M | 26.47M | 34.65M | 31.72M | 41.78M | 45.77M | 29.48M | 24.76M | 25.2M | 29.38M | 26.75M | 17.07M | 20.89M | 18.21M | 11.21M | 9.85M |
Other Expenses | -191K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 324K | 95K | -233K | -9K | -7K | -11K | 16K | 14K | 28K | 26K |
Operating Expenses | 23.28M | 31.82M | 30.61M | 32.57M | 41.3M | 37.55M | 47.82M | 53.27M | 36.78M | 32.2M | 32.22M | 36.68M | 33.79M | 24.75M | 28.47M | 24.58M | 16.3M | 14.21M |
Interest Expense | 405K | 406K | 427K | 446K | 429K | 427K | 415K | 391K | 372K | 387K | n/a | 2K | 2K | 3K | 3K | 4K | 3K | 3K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -220K | -214K | -207K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 23.47M | 31.82M | 30.61M | 32.57M | 41.52M | 37.76M | 48.02M | 53.27M | 36.78M | 32.2M | 32.22M | 36.68M | 33.79M | 24.75M | 28.47M | 24.58M | 16.3M | 14.21M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -209K | n/a | -1.63M | 64K | n/a | -869K | -214K | -21K | 18K | 31K | 29K |
Shares Outstanding (Basic) | 53.45M | 53.36M | 52.8M | 52.69M | 51.83M | 50.12M | 49M | 41.15M | 40.88M | 40.86M | 40.76M | 40.75M | 40.69M | 40.62M | 40.53M | 40.4M | 40.25M | 40.06M |
Shares Outstanding (Diluted) | 53.45M | 53.36M | 52.8M | 52.69M | 51.83M | 50.12M | 49M | 41.15M | 40.88M | 40.86M | 40.76M | 40.75M | 40.69M | 40.62M | 40.53M | 40.4M | 40.25M | 40.06M |
EPS (Basic) | -0.49 | -0.58 | -0.55 | -0.58 | -0.76 | -0.71 | -0.93 | -1.24 | -0.84 | -0.7 | -0.75 | -0.87 | -0.79 | -0.6 | -0.7 | -0.61 | -0.4 | -0.35 |
EPS (Diluted) | -0.49 | -0.58 | -0.55 | -0.58 | -0.76 | -0.71 | -0.93 | -1.24 | -0.84 | -0.7 | -0.75 | -0.87 | -0.79 | -0.6 | -0.7 | -0.61 | -0.4 | -0.35 |
EBITDA | -26.65M | -30.14M | -28.52M | -30.04M | -38.75M | -34.94M | -44.85M | -50.39M | -33.27M | -29.28M | -32.11M | -34.92M | -32.64M | -24.16M | -28.42M | -24.56M | -16.27M | -14.2M |
EBIT | -25.54M | -30.35M | -28.74M | -30.26M | -38.97M | -35.15M | -45.06M | -50.6M | -33.79M | -29.8M | -32.22M | -35.32M | -32.92M | -24.53M | -28.46M | -24.58M | -16.3M | -14.21M |
Depreciation & Amortization | 191K | 211K | 214K | 224K | 220K | 214K | 207K | 209K | 513K | 518K | 413K | 95K | 280K | 376K | 259K | 262K | 152K | 5K |